The introduction of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators, specifically the triple combination of elexacaftor, tezacaftor, and ivacaftor (ETI, TRIKAFTA®), has led to an increased life expectancy in people with CF [7]. This evidence concerns the gene CFTR and cystic fibrosis.